Targeted binding agents against B7-H1

Details for Australian Patent Application No. 2010324757 (hide)

Owner MedImmune Limited

Inventors Queva, Christophe; Morrow, Michelle; Hammond, Scott; Alimzhanov, Marat; Babcock, John; Foltz, Ian; Kang, Jaspal Singh; Sekirov, Laura; Boyle, Melanie; Chodorge, Matthieu

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2010324757

PCT Pub. Number WO2011/066389

Priority 61/264,061 24.11.09 US

Filing date 24 November 2010

Wipo publication date 3 June 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

24 May 2012 PCT application entered the National Phase

  PCT publication WO2011/066389 Priority application(s): WO2011/066389

7 June 2012 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read Queva, Christophe; Morrow, Michelle; Hammond, Scott; Alimzhanov, Marat; Babcock, John; Foltz, Ian; Kang, Jaspal Singh; Sekirov, Laura; Boyle, Melanie; Chodorge, Matthieu; Stewart, Ross and Mulgrew, Kathleen Ann

20 September 2012 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read Queva, Christophe; Morrow, Michelle; Hammond, Scott; Alimzhanov, Marat; Babcook, John; Foltz, Ian; Kang, Jaspal Singh; Sekirov, Laura; Boyle, Melanie; Chodorge, Matthieu; Stewart, Ross and Mulgrew, Kathleen Ann

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010324763-Interaction terminal

2010324752-AAD-12 event 416, related transgenic soybean lines, and event-specific identification thereof